Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer

NCT00360971 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

21

Enrollment

NETWORK

Sponsor class

Stopped Due to positive preliminary results from other palifermin studies.

Conditions

Head and Neck Cancer
Mucositis
Pain
Radiation Toxicity

Interventions

BIOLOGICAL: palifermin
DRUG: cisplatin
OTHER: placebo
PROCEDURE: neck dissection
RADIATION: radiation therapy

Sponsor

Radiation Therapy Oncology Group

Collaborators

[object Object]